ArticleOncogene2015
A chromatin modifier genetic screen identifies SIRT2 as a modulator of response to targeted therapies through the regulation of MEK kinase activity.
P K Bajpe et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it